Showing results (11-20 of 129) with videos related to
Sort By:
Pageof 13
Pathophysiology of Haemostasis and Thrombosis|August 1, 2006
Lipoprotein(a) and thrombocytes: potential mechanisms underlying cardiovascular riskWilliam Discepolo, Ted Wun, Lars BerglundJournal of Registry Management|April 20, 2013
A method to identify California's sickle-cell disease population and its linkage to the California Cancer RegistryMonica Brown, Ann Brunson, Ted WunThrombosis Research|November 21, 2007
Targeting patients for anticoagulant prophylaxis trials in patients with cancer: who is at highest risk?Richard H White, Helen Chew, Ted WunLeukemia Research|December 5, 2003
Increased cyclooxygenase-2 (COX-2): a potential role in the pathogenesis of lymphomaTed Wun, Hayes McKnight, Joseph M TuscanoCancer|November 17, 2011
Risk assessment models for cancer-associated venous thromboembolismMrinal Dutia, Richard H White, Ted WunThrombosis Research|March 10, 2015
Vena cava filter use in cancer patients with acute venous thromboembolism in CaliforniaGwendolyn Ho, Ann Brunson, Richard White, et al.Journal of Hematology & Oncology|December 3, 2008
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): a 24-year clinical experience with 178 patientsMark Levandovsky, Danielle Harvey, Primo Lara, et al.Thrombosis Research|April 13, 2016
Inferior vena cava filters in patients with cancer and venous thromboembolism (VTE): patterns of use and outcomesAnn Brunson, Gwendolyn Ho, Richard White, et al.Thrombosis Research|March 24, 2017
Inferior vena cava filters in patients with cancer and venous thromboembolism (VTE) does not improve clinical outcomes: A population-based studyAnn Brunson, Gwendolyn Ho, Richard White, et al.Seminars in Thrombosis and Hemostasis|May 2, 2019
The Epidemiology of Cancer-Associated Venous Thromboembolism: An UpdateAnjlee Mahajan, Ann Brunson, Richard White, et al.Pageof 13